Autoimmune hepatitis articles from across Nature Portfolio

Autoimmune hepatitis is a chronic self-perpetuating inflammation of the liver with unknown aetiology. It is usually associated with hypergammaglobulinaemia and autoantibodies.

Latest Research and Reviews

Research
10 March 2023 | Open Access

A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data
- Haiyan Yang
- , Lingying Huang
- & Jianjun Hu
Scientific Reports 13, 3996
Research
09 December 2022 | Open Access

Mechanistic target of rapamycin complex 1 orchestrates the interplay between hepatocytes and Kupffer cells to determine the outcome of immune-mediated hepatitis
- Xiaoli Sun
- , Yajie Ni
- & Chunsun Dai
Cell Death & Disease 13, 1031
Research
07 March 2022 | Open Access

LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease
- Dongmei Zou
- , Liang Liu
- & Mingguo Xu
Cell Death Discovery 8, 103
Research
27 July 2021 | Open Access

Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease
- Kamil Janowski
- , Elizabeth Shumbayawonda
- & Piotr Socha
Scientific Reports 11, 15261
Research
04 March 2021 | Open Access

Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression
- Qiuli Liu
- , Xiaoyong Chen
- & Qi Zhang
Cell Death & Disease 12, 240
Research
09 December 2020 | Open Access

Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-κB signaling
- Yoo Kim
- , Sudeep Gautam
- & Josephine M. Egan
Cell Death & Disease 11, 1044

All Research & Reviews

News and Comment

Research Highlights | 13 December 2011

New predictor of response to treatment in autoimmune hepatitis type 1

Nature Reviews Gastroenterology & Hepatology 9, 5
News & Views | 23 August 2011

Liver biopsy differentiates DILI from autoimmune hepatitis

A new study explores the use of liver biopsy to differentiate drug-induced liver injury (DILI) from autoimmune hepatitis. However, not all that glitters is necessarily the gold standard—disagreement among experts on the histological features of DILI could create uncertainty over the accuracy of this diagnostic approach.
- James H. Lewis
Nature Reviews Gastroenterology & Hepatology 8, 540-542
Research Highlights | 07 March 2011

Scores predict treatment failure
- Claire Greenhill
Nature Reviews Gastroenterology & Hepatology 8, 121

All News & Comment

Autoimmune hepatitis articles from across Nature Portfolio

Latest Research and Reviews

A diagnostic model of autoimmune hepatitis in unknown liver injury based on noninvasive clinical data

Mechanistic target of rapamycin complex 1 orchestrates the interplay between hepatocytes and Kupffer cells to determine the outcome of immune-mediated hepatitis

LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease

Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease

Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression

Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-κB signaling

News and Comment

New predictor of response to treatment in autoimmune hepatitis type 1

Liver biopsy differentiates DILI from autoimmune hepatitis

Scores predict treatment failure

Search

Quick links